Skip to content

Positive Emotion Regulation Training in Children, Adolescents and Young Adults With and Without Developmental Disorder

Positive Emotion Regulation Training in Children, Adolescents and Young Adults With and Without Developmental Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02898298
Acronym
ERICA
Enrollment
60
Registered
2016-09-13
Start date
2016-08-31
Completion date
2020-12-31
Last updated
2021-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodevelopmental Disorders

Brief summary

The purpose of this study is to evaluate the efficacy of a novel positive emotion regulation intervention that aims to increase positive emotions and improve emotion regulation skills in children, adolescents and young adults. The study focuses on individuals with a developmental disorder such as Autism Spectrum Disorder and other Learning or Developmental Disabilities in comparison to typically developing (TD) controls. Participants will complete a psycho-educative training to learn about positive emotions and how to increase them in their daily lives. Participants are expected to benefit from the training, which will be evident in a change in emotion experience, emotion regulation strategy use, and well-being. Emotion regulation efficacy will be related to symptom severity (autistic symptoms), alexithymia and problematic behaviors.

Detailed description

This study aims at testing the efficacy of a 3-session psycho-educative training on emotion regulation and wellbeing in children and adolescents with or without developmental disorders with a waitlist control group design. Specifically, we are interested to improve different aspects of emotions, such as emotion experience, regulation strategy use, and beliefs on the malleability of emotions. Given that most of the past and actual interventions focus on negative emotions, our training will allow participants to learn more about positive emotions, how they can increase them, and how they can benefit from them. Individuals with a developmental disorder including Autism Spectrum Disorder (ASD) will be recruited via flyers in specialized institutions and schools. Individuals with typical development (TD) will be recruited via flyers in schools, universities, libraries, and in other public places. Participants will be randomly assigned to the training or waiting list group (control). Randomization will be stratified for the two populations (i.e. with and without a developmental disorder) and for age. Participants and one of their parents (if \<18 years) will be asked to fill in questionnaires on emotion experience, emotion regulation, beliefs about the malleability of emotions, well-being, problematic behaviors, alexithymia, and ASD symptom severity at four time points. Some questionnaires will only be completed by parents. Participants will be asked to answer additional questions on their emotional experience and emotion regulation and to provide examples of their own emotional experience and emotion regulation during and after each of the training sessions. Participants are expected to benefit from the intervention, which should become evident in the changes of the primary outcome measures (emotion experience, emotion regulation, beliefs about the malleability of emotions, well-being) and the secondary outcome measures (problematic behaviors, alexithymia, and ASD symptom severity) post-intervention and at 8-weeks follow up.

Interventions

BEHAVIORALPositive Emotion Regulation Training

Participants will receive a 3-session psycho-educative training on emotion regulation.

Sponsors

University of Geneva, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants between 10-35 years old, presenting or not a developmental disorder (e.g., autism).

Exclusion criteria

* Participants who are not able to understand the training instructions.

Design outcomes

Primary

MeasureTime frameDescription
Change in Subjective Happiness ScaleWeek 1, Week 5, Week 9, Week 13 or 17Change in well-being. Week 13 for immediate group, Week 17 for waitlist group.
Change in Positive and Negative Affect ScaleWeek 1, Week 5, Week 9, Week 13 or 17Change in emotion experience. Week 13 for immediate group, Week 17 for waitlist group.
Change in Emotion Regulation QuestionnaireWeek 1, Week 5, Week 9, Week 13 or 17Change in emotion regulation strategy use. Week 13 for immediate group, Week 17 for waitlist group.
Change in Satisfaction with Life ScaleWeek 1, Week 5, Week 9, Week 13 or 17Change in well-being. Week 13 for immediate group, Week 17 for waitlist group.

Secondary

MeasureTime frameDescription
Change in Toronto Alexithymia ScaleWeek 1, Week 5, Week 9, Week 13 or 17Change in alexithymia scores. Week 13 for immediate group, Week 17 for waitlist group.
Change in Strength and Difficulties QuestionnaireWeek 1, Week 5, Week 9, Week 13 or 17Change in problematic behavior. Week 13 for immediate group, Week 17 for waitlist group.
Change in Autism Spectrum QuotientWeek 1, Week 5, Week 9, Week 13 or 17Change in autism symptom severity. Week 13 for immediate group, Week 17 for waitlist group.

Other

MeasureTime frameDescription
Participants' experience and satisfaction with training (satisfaction questionnaire)Week 13 or 17Week 13 for immediate group, Week 17 for waitlist group.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026